Laura Uwakwe
General Practice · Philadelphia, PANPI 1073929360
Payments from drug & device makers
Across 68 payments — averaging $29.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$332
- AbbVie$276
- Janssen Scientific Affairs, LLC$238
- Sun Pharmaceutical Industries Inc.$205
- Arcutis Biotherapeutics, Inc.$152
- Johnson & Johnson$149
- plus $637 from 17 others
What the payments were for
- Food & beverage$1,989100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 9 | $332 |
| AbbVie | 12 | $276 |
| Janssen Scientific Affairs, LLC | 2 | $238 |
| Sun Pharmaceutical Industries Inc. | 5 | $205 |
| Arcutis Biotherapeutics, Inc. | 6 | $152 |
| Johnson & Johnson | 7 | $149 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $88 |
| Incyte Corporation | 3 | $64 |
| Lilly USA, LLC | 2 | $60 |
| Novartis | 2 | $58 |
| Boehringer Ingelheim | 2 | $54 |
| UCB, Inc. | 2 | $45 |
| Galderma Laboratories, L.p. | 2 | $44 |
| Amgen | 1 | $31 |
| VYNE Pharmaceuticals Inc. | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Biofrontera Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| Dermira, Inc. | 1 | $15 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$145
How this compares
$1,989 in reported general payments places this provider in the 90th percentile of 3,208 general practice providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $94,255 |
| Tacrolimus | 17 | $4,525 |
| Ketoconazole | 54 | $1,158 |
| Clindamycin Phosphate | 17 | $575 |
| Triamcinolone Acetonide | 16 | $244 |
| Hydrocortisone | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other general practice in Philadelphia
- Corey AnolikPhiladelphia$2.1M
- Alan AtlasPhiladelphia$486K
- Marc ManosPhiladelphia$85K
- Joseph PreziosiPhiladelphia$18K
- Mark WolffPhiladelphia$13K
- Jordan BowerPhiladelphia$13K
- Leonard TauPhiladelphia$12K
- Stephen WilfredPhiladelphia$6K
- Jeffrey GazzaraPhiladelphia$6K
- Richard NagelbergPlymouth Meeting$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.